43 related articles for article (PubMed ID: 33865565)
1. Is low radioiodine uptake a contraindication to radioiodine therapy in patients with benign thyroid disease?
Płazińska MT; Czarnywojtek A; Sawicka-Gutaj N; Woliński K; Krela-Kaźmierczak I; Zgorzalewicz-Stachowiak M; Miechowicz I; Gut P; Florek E; Skonieczna-Żydecka K; Ruchała M; Królicki L
Adv Clin Exp Med; 2021 Apr; 30(4):369-378. PubMed ID: 33913262
[TBL] [Abstract][Full Text] [Related]
2. Investigating the prevalence of primary thyroid dysfunction in obese and overweight individuals: Tehran thyroid study.
Mahdavi M; Amouzegar A; Mehran L; Madreseh E; Tohidi M; Azizi F
BMC Endocr Disord; 2021 Apr; 21(1):89. PubMed ID: 33931052
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Graves' Disease Patients Following Antithyroid Drugs, Radioactive Iodine, or Thyroidectomy as the First-line Treatment.
Liu X; Wong CKH; Chan WWL; Tang EHM; Woo YC; Lam CLK; Lang BHH
Ann Surg; 2021 Jun; 273(6):1197-1206. PubMed ID: 33914484
[TBL] [Abstract][Full Text] [Related]
4. Changes in Thyrotropin Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease.
Kim J; Choi MS; Park J; Park H; Jang HW; Choe JH; Kim JH; Kim JS; Cho YS; Choi JY; Kim TH; Chung JH; Kim SW
Thyroid; 2021 Aug; 31(8):1264-1271. PubMed ID: 33947272
[No Abstract] [Full Text] [Related]
5. Treatment of Hyperthyroidism Reduces Systemic Oxidative Stress, as Measured by Markers of RNA and DNA Damage.
Larsen CB; Riis KR; Winther KH; Larsen EL; Ellervik C; Hegedüs L; Brix TH; Poulsen HE; Bonnema SJ
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2512-e2520. PubMed ID: 33901280
[TBL] [Abstract][Full Text] [Related]
6. Does Age or Sex Relate to Severity or Treatment Prognosis in Graves' Disease?
Suzuki N; Noh JY; Yoshimura R; Mikura K; Kinoshita A; Suzuki A; Mitsumatsu T; Hoshiyama A; Fukushita M; Matsumoto M; Yoshihara A; Watanabe N; Sugino K; Ito K
Thyroid; 2021 Sep; 31(9):1409-1415. PubMed ID: 33882721
[No Abstract] [Full Text] [Related]
7. Prospective study to evaluate radioactive iodine of 20 mCi vs 10-15 mCi in Graves' disease.
Kanokwongnuwat W; Penpong N
BMC Endocr Disord; 2024 Apr; 24(1):54. PubMed ID: 38664774
[TBL] [Abstract][Full Text] [Related]
8. Hyperthyroidism: A Review.
Lee SY; Pearce EN
JAMA; 2023 Oct; 330(15):1472-1483. PubMed ID: 37847271
[TBL] [Abstract][Full Text] [Related]
9. Effect of liver dysfunction on outcome of radioactive iodine therapy for Graves' disease.
Ze Y; Shao F; Feng X; Shen S; Bi Y; Zhu D; Zhang X
BMC Endocr Disord; 2022 Dec; 22(1):319. PubMed ID: 36522617
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves' Disease.
Kim MJ; Cho SW; Kim YA; Choi HS; Park YJ; Park DJ; Cho BY
Endocrinol Metab (Seoul); 2022 Jun; 37(3):524-532. PubMed ID: 35709827
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves' disease patients.
Hu RT; Liu DS; Li B
BMC Endocr Disord; 2020 May; 20(1):76. PubMed ID: 32471411
[TBL] [Abstract][Full Text] [Related]
12. Radioiodine treatment in pediatric Graves' disease and thyroid carcinoma.
Yuan L; Yang J
J Pediatr Endocrinol Metab; 2011; 24(11-12):877-83. PubMed ID: 22308835
[TBL] [Abstract][Full Text] [Related]
13. Comparison of long-term antithyroid drugs versus radioactive iodine or surgery for Graves' disease: A review of the literature.
El Kawkgi OM; Ross DS; Stan MN
Clin Endocrinol (Oxf); 2021 Jul; 95(1):3-12. PubMed ID: 33283314
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors of radioiodine therapy failure in Graves' Disease: A meta-analysis.
Shalaby M; Hadedeya D; Toraih EA; Razavi MA; Lee GS; Hussein MH; Weidenhaft MC; Serou MJ; Ibraheem K; Abdelgawad M; Kandil E
Am J Surg; 2022 Feb; 223(2):287-296. PubMed ID: 33865565
[TBL] [Abstract][Full Text] [Related]
15. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factor analysis in 325 patients with Graves' disease treated with radioiodine therapy.
Yang D; Xue J; Ma W; Liu F; Fan Y; Rong J; Yang A; Yu Y
Nucl Med Commun; 2018 Jan; 39(1):16-21. PubMed ID: 29040161
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
